Intuitive Surgical Rating Downgraded to 'Hold' by Zacks Research

Analysts cite concerns over the medical device company's future performance

Apr. 1, 2026 at 11:06am

Got story updates? Submit your updates here. ›

Intuitive Surgical (NASDAQ:ISRG), a leading provider of robotic-assisted surgical systems, has been downgraded from a 'strong-buy' rating to a 'hold' rating by research firm Zacks Research. The move comes as analysts reevaluate the company's growth prospects amid a shifting healthcare landscape.

Why it matters

Intuitive Surgical's da Vinci surgical systems have been a dominant force in minimally invasive procedures, but the company now faces increased competition and potential headwinds. The downgrade by a respected research firm could signal broader concerns about the company's ability to maintain its market leadership position.

The details

Zacks Research cited a number of factors in its decision to downgrade Intuitive Surgical, including increased competition from other robotic surgery providers, potential regulatory changes, and uncertainty around hospital spending on new medical technologies. The firm also noted that while Intuitive has a strong track record, its valuation may be stretched at current levels.

  • Zacks Research issued the downgrade on Monday, April 1, 2026.

The players

Intuitive Surgical

A medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems, best known for its da Vinci surgical platforms.

Zacks Research

A respected equity research firm that provides investment analysis and ratings on public companies.

Got photos? Submit your photos here. ›

What they’re saying

“We must reevaluate Intuitive Surgical's growth prospects in light of increased competition and potential headwinds facing the company.”

— Zacks Research Analyst

What’s next

Investors will be closely watching Intuitive Surgical's upcoming earnings report and guidance to gauge the company's ability to navigate the evolving healthcare landscape.

The takeaway

The downgrade by Zacks Research underscores the challenges facing Intuitive Surgical as it seeks to maintain its leadership in the robotic surgery market. The company will need to demonstrate its ability to adapt and innovate in order to fend off competitors and sustain its growth trajectory.